fr

EN DE

fr

EN DE

Publications

2108 PUBLICATIONS - effacer la recherche

ANNÉE

JOURNAL

PREMIER AUTEUR

TITRE

2022

Cancer cell international

Douyère M

NRP1 inhibition modulates radiosensitivity of medulloblastoma by targeting cancer stem cells.

2022

Quantitative imaging in medicine and surgery

Asuncion A

Prediction of prostate cancer recurrence after radiation therapy using multiparametric magnetic resonance imaging and spectroscopy: assessment of prognostic factors on pretreatment imaging.

2022

Biomedicines

Dumetier B

Repeat Element Activation-Driven Inflammation: Role of NFκB and Implications in Normal Development and Cancer?

2022

Bulletin du cancer

Minot L

[Examining the use of palliative systemic treatments near end-of-life for patients with metastatic cancer at a French cancer institute].

2022

Macromolecular bioscience

Baka Z

A Coculture Based, 3D Bioprinted Ovarian Tumor Model Combining Cancer Cells and Cancer Associated Fibroblasts.

2022

Clinical cancer research : an official journal of the American Association for Cancer Research

Ladoire S

Associating immunotherapy and targeted therapies: facts and hopes.

2022

Pharmaceuticals (Basel, Switzerland)

Ariztia J

Clickable -Glycosyl Scaffold for the Development of a Dual Fluorescent and [F]fluorinated Cyanine-Containing Probe and Preliminary In Vitro/Vivo Evaluation by Fluorescence Imaging.

2022

International journal of molecular sciences

Frenay J

IL-1RAP, a Key Therapeutic Target in Cancer.

2022

BMC cancer

Dupont M

Incidence and associated factors of cetuximab-induced hypersensitivity infusion reactions in 1392 cancer patients treated in four French areas: a possible association with Lyme disease?

2022

BMC cancer

Coquan E

TALASUR trial: a single arm phase II trial assessing efficacy and safety of TALazoparib and Avelumab as maintenance therapy in platinum-Sensitive metastatic or locally advanced URothelial carcinoma.